Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Soluble CD83 proteins and use thereof for the treatment and prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells

Soluble CD83 proteins and use thereof for the treatment and prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells

US Patent 8124099 · Granted Feb 28, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mutant CD83 promoter and use thereof2017
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment o2017
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment o2017
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment o2017
Nucleic acid of recombination expression vector encoding soluble forms of CD83, 2015
Nucleic acid of recombination expression vector encoding soluble forms of CD83, 2015
Nucleic acid of recombination expression vector encoding soluble forms of CD83, 2015
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment o2014
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment o2014
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment o2014
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment o2011
Use of soluble forms of CD83 and nucleic acids encoding them for the treatment o2011